Conmed announced that it plans to exit its gastroenterology product lines as part of a broader portfolio optimization strategy. Part of the exit includes the end of the company's distribution agreement with W.L. Gore & Associates related to … [Read More...] about Conmed to exit gastroenterology product lines, transfer Gore Viabil rights to Olympus
Main Content
Medical Tubing & Extrusion
Conmed to exit gastroenterology product lines, transfer Gore Viabil rights to Olympus
Conmed announced that it plans to exit its gastroenterology product lines as part of a broader portfolio optimization strategy. Part of the exit includes the end of the company's distribution agreement with W.L. Gore & Associates related to … [Read More...] about Conmed to exit gastroenterology product lines, transfer Gore Viabil rights to Olympus
Boston Scientific gets European nod for Farapoint catheter
Boston Scientific announced recently that it received CE mark for its Farapoint pulsed field ablation (PFA) catheter. The regulatory nod, earned last week, allows the Marlborough, Massachusetts-based company to bring the newest PFA catheter in its … [Read More...] about Boston Scientific gets European nod for Farapoint catheter
Atraverse wins FDA clearance for left heart access device
Atraverse Medical announced today that it received FDA clearance for its fully integrated Hotwire transseptal access system. Hotwire is a novel radiofrequency guidewire left-heart access device. It enables zero exchange left-heart access while … [Read More...] about Atraverse wins FDA clearance for left heart access device
Procyrion adds former Silk Road Medical exec as new CCO
Procyrion announced today that it appointed Andrew Davis as its new chief commercial officer (CCO), effective immediately. Houston-based Procyrion develops a catheter-deployed percutaneous mechanical circulatory support (pMCS) device called … [Read More...] about Procyrion adds former Silk Road Medical exec as new CCO
Xeltis secures $55.1M to support aXess commercialization
Xeltis announced today that it secured €47.5 million ($55.1 million) in financing to support its vascular access device. The funding includes €37.5m ($43.5 million) in funding from the EIB, supported under the European Commission’s Invest EU … [Read More...] about Xeltis secures $55.1M to support aXess commercialization
Shifamed’s Akura Medical closes $53M Series C
Akura Medical, a Shifamed portfolio company, announced today that it completed the first close of its Series C financing, raising $53 million. Los Gatos, California-based Akura plans to use funds to support development activities for its Katana … [Read More...] about Shifamed’s Akura Medical closes $53M Series C
Imperative Care reports positive results for next-gen stroke aspiration approach
Imperative Care announced new real-world data evaluating ADAPT 2.0, a next-generation approach to stroke treatment. ADAPT (A Direct Aspiration First Pass Technique) 2.0 combines 0.088” intracranial access, asymmetric aspiration, and the continuous … [Read More...] about Imperative Care reports positive results for next-gen stroke aspiration approach
